Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for Zimmer, Inc.�
-2.50 (-2.56%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 94.71 - 96.49
52 week 88.77 - 121.84
Open 96.06
Vol / Avg. 3.95M/1.51M
Mkt cap 18.86B
P/E 393.60
Div/yield 0.22/0.93
EPS 0.24
Shares 203.70M
Beta 0.94
Inst. own 79%
May 4, 2016
Zimmer Holdings Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:30AM EDT - Add to calendar
Jan 28, 2016
Q4 2015 Zimmer Biomet Holdings Inc Earnings Call - Webcast
Jan 28, 2016
Q4 2015 Zimmer Biomet Holdings Inc Earnings Release
Jan 12, 2016
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference - Q&A Session
Jan 12, 2016
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference
Dec 1, 2015
Zimmer Biomet Holdings Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 1.52% 0.82%
Operating margin 3.75% 5.44%
EBITD margin - 32.60%
Return on average assets 0.44% 0.26%
Return on average equity 1.20% 0.61%
Employees 10,000 -
CDP Score - 58 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Joseph Anthony Cucolo President, Americas
Age: 56
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 51
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Controller
Age: 46
Bio & Compensation  - Reuters
Derek M. Davis Vice President - Global Integration
Age: 46
Bio & Compensation  - Reuters
Larry C. Glasscock Independent Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Michael J. Farrell Director
Age: 43
Bio & Compensation  - Reuters
Michael W. Michelson Director
Age: 63
Bio & Compensation  - Reuters